智慧藥物遞輸系統的全球市場預測(～2028年):各產品，各治療領域，各終端用戶，各藥物輸送模式，各地區的分析

全球智慧藥物遞輸系統的市場規模，預計從2022年的87億美元，到2028年達到225億美元，在預測期間內以17.2％的年複合成長率成長。

本報告提供全球智慧藥物遞輸系統市場相關調查分析，市場趨勢，成長促進、阻礙因素，各市場區隔、各地區的分析，企業簡介等資訊。

目錄

第1章 摘要整理

第2章 序文

第3章 市場趨勢分析

• 促進因素
• 阻礙因素
• 機會
• 威脅
• 產品分析
• 終端用戶分析
• 新興市場
• COVID-19影響

第4章 波特的五力分析

第5章 全球智慧藥物遞輸系統市場:各產品

• 連接的筆注射器
• 連接的吸入器
• 連接的自動注射器
• 連接的穿戴式注射器
• 附加元件感測器
• 其他的產品

第6章 全球智慧藥物遞輸系統市場:各治療領域

• 呼吸疾病
• 神經學的障礙
• 荷爾蒙障礙
• 代謝障礙
• 其他的治療領域

第7章 全球智慧藥物遞輸系統市場:各藥物輸送模式

• 注射可能
• 口服
• 吸入

第8章 全球智慧藥物遞輸系統市場:各終端用戶

• 醫院
• 居家照護
• 診療所
• 其他終端用戶

第9章 全球智慧藥物遞輸系統市場:各地區

• 北美
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙
  • 其他歐洲
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 澳洲
  • 紐西蘭
  • 韓國
  • 其他亞太地區
• 南美
  • 阿根廷
  • 巴西
  • 智利
  • 其他南美
• 中東、非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 卡達
  • 南非
  • 其他中東、非洲

第10章 主要發展

• 契約，夥伴關係，聯盟，合資企業
• 收購與合併
• 新產品的銷售
• 擴張
• 其他的主要策略

第11章 企業簡介

• Novo Nordisk A/S
• E3D Elcam Drug Delivery Devices
• Sonceboz
• Phillips-Medisize
• West Pharmaceutical Services Inc.
• Abbott Laboratories
• Adherium Ltd
• H&T Presspart Manufacturing Ltd
• Becton, Dickinson and Company
• Amiko Digital Health Limited
• CeQur Corporation
• BIOCORP
• CeQur Corporation
• Cognita Labs
• HCmed Innovations Co., Ltd.
• Medtronic plc

According to Stratistics MRC, the Global Smart Drug Delivery System Market is accounted for $8.7 billion in 2022 and is expected to reach $22.5 billion by 2028 growing at a CAGR of 17.2% during the forecast period. Smart Drug Delivery Systems are devices that can perform multiple functions with the greatest degree of intelligence. Smart drug delivery devices help to reduce dosage, frequency of administration, and adverse drug effects. Smart drug delivery systems that are connected are more effective and self-manageable. The COVID-19 Pandemic is significantly increased the demand for such smart (contactless) devices, and thus, in the future, there will be a high demand for such systems.

According to a World Health Organization (WHO) fact sheet from 2017, Cardiovascular diseases are the leading cause of death, with 17.9 million deaths reported globally in 2016. The easy availability of advanced products, as well as increased awareness about them expected to drive the Smart drug delivery systems market forward.

Market Dynamics:

Driver:

Rising Prevalence of Chronic Diseases

Numerous new drug delivery systems are in high demand to improve drug efficacy for chronic diseases such as diabetes, cancer, atherosclerosis, myocardial ischemia, asthma, pulmonary tuberculosis, Parkinson's disease, and Alzheimer's disease. Non-long-acting drug delivery systems (LADDS) are used to treat chronic diseases. Non-long-acting drug delivery systems (LADDS) are used to treat chronic diseases. Drug molecules are delivered to target tissues via systemic circulation or localised injections. During the forecast period, such factors will propel the market's growth.

Restraint:

Stringent Regulations

Some of the key factors that regulatory bodies consider are safety, efficacy, pharmacological data, pharmacodynamic effects, and drug interactions. As a result, a drug that fails to meet these criteria is likely to receive a complete response letter (CRL) or face total rejection from regulatory agencies. After receiving a CRL, a drug applicant is required to provide additional data about the drug, which may necessitate additional clinical trials.

Opportunity:

Advanced research and development

Big and local producers can now create a wide range of products thanks to ongoing innovation in the market for drug delivery systems. Collaborations between top industry players for improved technical developments in drug delivery solutions. Major industrial companies constantly engage in research and development to expand their already wide range of product offerings. The global market for drug delivery systems is anticipated to grow as a result of the ongoing expansion of drug delivery systems with high throughput, reduced waiting time, and improved result specificity.

Threat:

Self Medications

As medical technology companies strive to make their products more patient-centric, self-medication solutions are becoming more popular around the world. A number of significant breakthroughs are expected to influence and revolutionise the field of advanced drug delivery in the near future. Poor patient compliance is a major issue in the pharmaceutical and healthcare industries as a whole. Noncompliance rates haven't changed much in the last 25 years, and they're likely to rise even more in the near future. As a result, industry participants are working on solutions that will allow medications to reach therapeutic levels without the need for repeated administration. Therefore, these factors may impact the market's growth in the near future.

COVID-19 Impact

Globally, significant R&D efforts are being made to combat COVID-19. Due to the pandemic, self-injection has grown in popularity, providing patients greater authority and control over their health and safety. Smart medication delivery system products make it possible to adjust injection speed, injection site pain, and treatment anxiety more effectively when receiving home healthcare.

The Connected Wearable Injectors segment is expected to be the largest during the forecast period

The Connected Wearable Injectors segment is estimated to have a lucrative growth and the trend is estimated to continue during the forecast timeline. Growing senior populace, increasing worries over needle stick injuries are expected to drive the segment's expansion. Besides, rise in chronic illnesses, and demand for constant health supervision are expected to add to the segment's growth.

The Hospitals segment is expected to have the highest CAGR during the forecast period

The Hospitals segment is anticipated to witness the fastest CAGR growth during the forecast period, as there are more pharmacies overall and more hospitals are utilising smart drug delivery systems. The healthcare industry had the largest market share in 2021. This can be attributed to hospitals using more smart medicine delivery systems, which are on the rise. The number of hospitals in the United States is expected to increase from 5,564 in 2017 to 6,093 by the year 2022, according to the American Hospital Association (AHA).

Region with highest share:

North America is anticipated to be the major contributor to the connected smart drug delivery systems market over the forecast years. The region is expected to maintain its leadership position during the projection years due to its high per capita healthcare spending, rapid adoption of the most recent technologies and gadgets, and increased awareness of the detrimental effects of non-compliance with drug therapy. The market in the U.S. and Canada is being driven by an increase in the adoption of novel and enhanced devices, early availability of advanced technologies, expansion in healthcare spending, presence of sophisticated healthcare infrastructure, and significant market participants.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to the inclination for self-administration of medications, improvements in injectable drug delivery systems, the high rate of adoption of new medical technologies, and the prevalence of chronic illnesses are the main factors driving the North American drug delivery systems market.

Key players in the market

Some of the key players profiled in the Smart Drug Delivery System Market include Novo Nordisk A/S, E3D Elcam Drug Delivery Devices, Sonceboz, Phillips-Medisize, West Pharmaceutical Services Inc., Abbott Laboratories, Adherium Ltd, H&T Presspart Manufacturing Ltd, Becton, Dickinson and Company, Amiko Digital Health Limited, CeQur Corporation, BIOCORP, CeQur Corporation, Cognita Labs, HCmed Innovations Co., Ltd. and Medtronic plc.

Key Developments:

In March 2022, Novo Nordisk recently expanded its oral medication delivery research relationship with the Massachusetts Institute of Technology (MIT) and Brigham and Women's Hospital (BWH). The cooperation will now last through 2026, with the scope expanded to cover the development and integration of bioelectronics, biosensors, and stimuli-responsive delivery systems.

In April 2022, Pneuma Systems Corporation has developed a multifaceted business partnership with West Pharmaceutical Services, Inc. with the purpose of enhancing patients' medication therapy experiences. West will employ Pneuma's unique closed-loop fluid flow management platform to create medication delivery solutions for pharmaceutical corporations and clinical end customers.

In May 2021, the U.S. Food and Drug Administration approved The Bigfoot Unity Diabetes Management System, which incorporates smart pen caps for disposable insulin pens and injection devices the size of a marker that diabetics use to inject insulin. The system integrates with Abbott's FreeStyle Libre 2 technology. Abbott partnered with Bigfoot Biomedical to provide automated information that personalizes diabetes management.

In December 2021, BIOCORP signed a new agreement with H&T Presspart (a division of Heitkamp & Thumann Group in Germany). The agreement includes integration and commercialization of InspairTM, a smart sensor designed by BIOCORP that converts inhalers into connected devices to assist patients suffering from asthma or chronic obstructive pulmonary disease (COPD) in receiving their treatment.

Products Covered:

• Connected Pen Injectors
• Connected Inhalers
• Connected Autoinjectors
• Connected Wearable Injectors
• Add-on Sensors
• Other Products

Therapeutic Areas Covered:

• Respiratory Disorders
• Neurological Disorders
• Hormonal Disorders
• Metabolic Disorders
• Other Therapeutic Areas

Drug Delivery Modes Covered:

• Injectable
• Oral
• Inhalation

End Users Covered:

• Hospitals
• Home Care
• Clinics
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Smart Drug Delivery System Market, By Product

• 5.1 Introduction
• 5.2 Connected Pen Injectors
• 5.3 Connected Inhalers
• 5.4 Connected Autoinjectors
• 5.5 Connected Wearable Injectors
• 5.6 Add-on Sensors
• 5.7 Other Products

6 Global Smart Drug Delivery System Market, By Therapeutic Area

• 6.1 Introduction
• 6.2 Respiratory Disorders
• 6.3 Neurological Disorders
• 6.4 Hormonal Disorders
• 6.5 Metabolic Disorders
• 6.6 Other Therapeutic Areas

7 Global Smart Drug Delivery System Market, By Drug Delivery Mode

• 7.1 Introduction
• 7.2 Injectable
• 7.3 Oral
• 7.4 Inhalation

8 Global Smart Drug Delivery System Market, By End User

• 8.1 Introduction
• 8.2 Hospitals
• 8.3 Home Care
• 8.4 Clinics
• 8.5 Others End Users

9 Global Smart Drug Delivery System Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Novo Nordisk A/S
• 11.2 E3D Elcam Drug Delivery Devices
• 11.3 Sonceboz
• 11.4 Phillips-Medisize
• 11.5 West Pharmaceutical Services Inc.
• 11.6 Abbott Laboratories
• 11.7 Adherium Ltd
• 11.8 H&T Presspart Manufacturing Ltd
• 11.9 Becton, Dickinson and Company
• 11.10 Amiko Digital Health Limited
• 11.11 CeQur Corporation
• 11.12 BIOCORP
• 11.13 CeQur Corporation
• 11.14 Cognita Labs
• 11.15 HCmed Innovations Co., Ltd.
• 11.16 Medtronic plc

List of Tables

• Table 1 Global Smart Drug Delivery System Market Outlook, By Region (2020-2028) ($MN)
• Table 2 Global Smart Drug Delivery System Market Outlook, By Product (2020-2028) ($MN)
• Table 3 Global Smart Drug Delivery System Market Outlook, By Connected Pen Injectors (2020-2028) ($MN)
• Table 4 Global Smart Drug Delivery System Market Outlook, By Connected Inhalers (2020-2028) ($MN)
• Table 5 Global Smart Drug Delivery System Market Outlook, By Connected Autoinjectors (2020-2028) ($MN)
• Table 6 Global Smart Drug Delivery System Market Outlook, By Connected Wearable Injectors (2020-2028) ($MN)
• Table 7 Global Smart Drug Delivery System Market Outlook, By Add-on Sensors (2020-2028) ($MN)
• Table 8 Global Smart Drug Delivery System Market Outlook, By Other Products (2020-2028) ($MN)
• Table 9 Global Smart Drug Delivery System Market Outlook, By Therapeutic Area (2020-2028) ($MN)
• Table 10 Global Smart Drug Delivery System Market Outlook, By Respiratory Disorders (2020-2028) ($MN)
• Table 11 Global Smart Drug Delivery System Market Outlook, By Neurological Disorders (2020-2028) ($MN)
• Table 12 Global Smart Drug Delivery System Market Outlook, By Hormonal Disorders (2020-2028) ($MN)
• Table 13 Global Smart Drug Delivery System Market Outlook, By Metabolic Disorders (2020-2028) ($MN)
• Table 14 Global Smart Drug Delivery System Market Outlook, By Other Therapeutic Areas (2020-2028) ($MN)
• Table 15 Global Smart Drug Delivery System Market Outlook, By Drug Delivery Mode (2020-2028) ($MN)
• Table 16 Global Smart Drug Delivery System Market Outlook, By Injectable (2020-2028) ($MN)
• Table 17 Global Smart Drug Delivery System Market Outlook, By Oral (2020-2028) ($MN)
• Table 18 Global Smart Drug Delivery System Market Outlook, By Inhalation (2020-2028) ($MN)
• Table 19 Global Smart Drug Delivery System Market Outlook, By End User (2020-2028) ($MN)
• Table 20 Global Smart Drug Delivery System Market Outlook, By Hospitals (2020-2028) ($MN)
• Table 21 Global Smart Drug Delivery System Market Outlook, By Home Care (2020-2028) ($MN)
• Table 22 Global Smart Drug Delivery System Market Outlook, By Clinics (2020-2028) ($MN)
• Table 23 Global Smart Drug Delivery System Market Outlook, By Others End Users (2020-2028) ($MN)
• Table 24 North America Smart Drug Delivery System Market Outlook, By Country (2020-2028) ($MN)
• Table 25 North America Smart Drug Delivery System Market Outlook, By Product (2020-2028) ($MN)
• Table 26 North America Smart Drug Delivery System Market Outlook, By Connected Pen Injectors (2020-2028) ($MN)
• Table 27 North America Smart Drug Delivery System Market Outlook, By Connected Inhalers (2020-2028) ($MN)
• Table 28 North America Smart Drug Delivery System Market Outlook, By Connected Autoinjectors (2020-2028) ($MN)
• Table 29 North America Smart Drug Delivery System Market Outlook, By Connected Wearable Injectors (2020-2028) ($MN)
• Table 30 North America Smart Drug Delivery System Market Outlook, By Add-on Sensors (2020-2028) ($MN)
• Table 31 North America Smart Drug Delivery System Market Outlook, By Other Products (2020-2028) ($MN)
• Table 32 North America Smart Drug Delivery System Market Outlook, By Therapeutic Area (2020-2028) ($MN)
• Table 33 North America Smart Drug Delivery System Market Outlook, By Respiratory Disorders (2020-2028) ($MN)
• Table 34 North America Smart Drug Delivery System Market Outlook, By Neurological Disorders (2020-2028) ($MN)
• Table 35 North America Smart Drug Delivery System Market Outlook, By Hormonal Disorders (2020-2028) ($MN)
• Table 36 North America Smart Drug Delivery System Market Outlook, By Metabolic Disorders (2020-2028) ($MN)
• Table 37 North America Smart Drug Delivery System Market Outlook, By Other Therapeutic Areas (2020-2028) ($MN)
• Table 38 North America Smart Drug Delivery System Market Outlook, By Drug Delivery Mode (2020-2028) ($MN)
• Table 39 North America Smart Drug Delivery System Market Outlook, By Injectable (2020-2028) ($MN)
• Table 40 North America Smart Drug Delivery System Market Outlook, By Oral (2020-2028) ($MN)
• Table 41 North America Smart Drug Delivery System Market Outlook, By Inhalation (2020-2028) ($MN)
• Table 42 North America Smart Drug Delivery System Market Outlook, By End User (2020-2028) ($MN)
• Table 43 North America Smart Drug Delivery System Market Outlook, By Hospitals (2020-2028) ($MN)
• Table 44 North America Smart Drug Delivery System Market Outlook, By Home Care (2020-2028) ($MN)
• Table 45 North America Smart Drug Delivery System Market Outlook, By Clinics (2020-2028) ($MN)
• Table 46 North America Smart Drug Delivery System Market Outlook, By Others End Users (2020-2028) ($MN)
• Table 47 Europe Smart Drug Delivery System Market Outlook, By Country (2020-2028) ($MN)
• Table 48 Europe Smart Drug Delivery System Market Outlook, By Product (2020-2028) ($MN)
• Table 49 Europe Smart Drug Delivery System Market Outlook, By Connected Pen Injectors (2020-2028) ($MN)
• Table 50 Europe Smart Drug Delivery System Market Outlook, By Connected Inhalers (2020-2028) ($MN)
• Table 51 Europe Smart Drug Delivery System Market Outlook, By Connected Autoinjectors (2020-2028) ($MN)
• Table 52 Europe Smart Drug Delivery System Market Outlook, By Connected Wearable Injectors (2020-2028) ($MN)
• Table 53 Europe Smart Drug Delivery System Market Outlook, By Add-on Sensors (2020-2028) ($MN)
• Table 54 Europe Smart Drug Delivery System Market Outlook, By Other Products (2020-2028) ($MN)
• Table 55 Europe Smart Drug Delivery System Market Outlook, By Therapeutic Area (2020-2028) ($MN)
• Table 56 Europe Smart Drug Delivery System Market Outlook, By Respiratory Disorders (2020-2028) ($MN)
• Table 57 Europe Smart Drug Delivery System Market Outlook, By Neurological Disorders (2020-2028) ($MN)
• Table 58 Europe Smart Drug Delivery System Market Outlook, By Hormonal Disorders (2020-2028) ($MN)
• Table 59 Europe Smart Drug Delivery System Market Outlook, By Metabolic Disorders (2020-2028) ($MN)
• Table 60 Europe Smart Drug Delivery System Market Outlook, By Other Therapeutic Areas (2020-2028) ($MN)
• Table 61 Europe Smart Drug Delivery System Market Outlook, By Drug Delivery Mode (2020-2028) ($MN)
• Table 62 Europe Smart Drug Delivery System Market Outlook, By Injectable (2020-2028) ($MN)
• Table 63 Europe Smart Drug Delivery System Market Outlook, By Oral (2020-2028) ($MN)
• Table 64 Europe Smart Drug Delivery System Market Outlook, By Inhalation (2020-2028) ($MN)
• Table 65 Europe Smart Drug Delivery System Market Outlook, By End User (2020-2028) ($MN)
• Table 66 Europe Smart Drug Delivery System Market Outlook, By Hospitals (2020-2028) ($MN)
• Table 67 Europe Smart Drug Delivery System Market Outlook, By Home Care (2020-2028) ($MN)
• Table 68 Europe Smart Drug Delivery System Market Outlook, By Clinics (2020-2028) ($MN)
• Table 69 Europe Smart Drug Delivery System Market Outlook, By Others End Users (2020-2028) ($MN)
• Table 70 Asia Pacific Smart Drug Delivery System Market Outlook, By Country (2020-2028) ($MN)
• Table 71 Asia Pacific Smart Drug Delivery System Market Outlook, By Product (2020-2028) ($MN)
• Table 72 Asia Pacific Smart Drug Delivery System Market Outlook, By Connected Pen Injectors (2020-2028) ($MN)
• Table 73 Asia Pacific Smart Drug Delivery System Market Outlook, By Connected Inhalers (2020-2028) ($MN)
• Table 74 Asia Pacific Smart Drug Delivery System Market Outlook, By Connected Autoinjectors (2020-2028) ($MN)
• Table 75 Asia Pacific Smart Drug Delivery System Market Outlook, By Connected Wearable Injectors (2020-2028) ($MN)
• Table 76 Asia Pacific Smart Drug Delivery System Market Outlook, By Add-on Sensors (2020-2028) ($MN)
• Table 77 Asia Pacific Smart Drug Delivery System Market Outlook, By Other Products (2020-2028) ($MN)
• Table 78 Asia Pacific Smart Drug Delivery System Market Outlook, By Therapeutic Area (2020-2028) ($MN)
• Table 79 Asia Pacific Smart Drug Delivery System Market Outlook, By Respiratory Disorders (2020-2028) ($MN)
• Table 80 Asia Pacific Smart Drug Delivery System Market Outlook, By Neurological Disorders (2020-2028) ($MN)
• Table 81 Asia Pacific Smart Drug Delivery System Market Outlook, By Hormonal Disorders (2020-2028) ($MN)
• Table 82 Asia Pacific Smart Drug Delivery System Market Outlook, By Metabolic Disorders (2020-2028) ($MN)
• Table 83 Asia Pacific Smart Drug Delivery System Market Outlook, By Other Therapeutic Areas (2020-2028) ($MN)
• Table 84 Asia Pacific Smart Drug Delivery System Market Outlook, By Drug Delivery Mode (2020-2028) ($MN)
• Table 85 Asia Pacific Smart Drug Delivery System Market Outlook, By Injectable (2020-2028) ($MN)
• Table 86 Asia Pacific Smart Drug Delivery System Market Outlook, By Oral (2020-2028) ($MN)
• Table 87 Asia Pacific Smart Drug Delivery System Market Outlook, By Inhalation (2020-2028) ($MN)
• Table 88 Asia Pacific Smart Drug Delivery System Market Outlook, By End User (2020-2028) ($MN)
• Table 89 Asia Pacific Smart Drug Delivery System Market Outlook, By Hospitals (2020-2028) ($MN)
• Table 90 Asia Pacific Smart Drug Delivery System Market Outlook, By Home Care (2020-2028) ($MN)
• Table 91 Asia Pacific Smart Drug Delivery System Market Outlook, By Clinics (2020-2028) ($MN)
• Table 92 Asia Pacific Smart Drug Delivery System Market Outlook, By Others End Users (2020-2028) ($MN)
• Table 93 South America Smart Drug Delivery System Market Outlook, By Country (2020-2028) ($MN)
• Table 94 South America Smart Drug Delivery System Market Outlook, By Product (2020-2028) ($MN)
• Table 95 South America Smart Drug Delivery System Market Outlook, By Connected Pen Injectors (2020-2028) ($MN)
• Table 96 South America Smart Drug Delivery System Market Outlook, By Connected Inhalers (2020-2028) ($MN)
• Table 97 South America Smart Drug Delivery System Market Outlook, By Connected Autoinjectors (2020-2028) ($MN)
• Table 98 South America Smart Drug Delivery System Market Outlook, By Connected Wearable Injectors (2020-2028) ($MN)
• Table 99 South America Smart Drug Delivery System Market Outlook, By Add-on Sensors (2020-2028) ($MN)
• Table 100 South America Smart Drug Delivery System Market Outlook, By Other Products (2020-2028) ($MN)
• Table 101 South America Smart Drug Delivery System Market Outlook, By Therapeutic Area (2020-2028) ($MN)
• Table 102 South America Smart Drug Delivery System Market Outlook, By Respiratory Disorders (2020-2028) ($MN)
• Table 103 South America Smart Drug Delivery System Market Outlook, By Neurological Disorders (2020-2028) ($MN)
• Table 104 South America Smart Drug Delivery System Market Outlook, By Hormonal Disorders (2020-2028) ($MN)
• Table 105 South America Smart Drug Delivery System Market Outlook, By Metabolic Disorders (2020-2028) ($MN)
• Table 106 South America Smart Drug Delivery System Market Outlook, By Other Therapeutic Areas (2020-2028) ($MN)
• Table 107 South America Smart Drug Delivery System Market Outlook, By Drug Delivery Mode (2020-2028) ($MN)
• Table 108 South America Smart Drug Delivery System Market Outlook, By Injectable (2020-2028) ($MN)
• Table 109 South America Smart Drug Delivery System Market Outlook, By Oral (2020-2028) ($MN)
• Table 110 South America Smart Drug Delivery System Market Outlook, By Inhalation (2020-2028) ($MN)
• Table 111 South America Smart Drug Delivery System Market Outlook, By End User (2020-2028) ($MN)
• Table 112 South America Smart Drug Delivery System Market Outlook, By Hospitals (2020-2028) ($MN)
• Table 113 South America Smart Drug Delivery System Market Outlook, By Home Care (2020-2028) ($MN)
• Table 114 South America Smart Drug Delivery System Market Outlook, By Clinics (2020-2028) ($MN)
• Table 115 South America Smart Drug Delivery System Market Outlook, By Others End Users (2020-2028) ($MN)
• Table 116 Middle East & Africa Smart Drug Delivery System Market Outlook, By Country (2020-2028) ($MN)
• Table 117 Middle East & Africa Smart Drug Delivery System Market Outlook, By Product (2020-2028) ($MN)
• Table 118 Middle East & Africa Smart Drug Delivery System Market Outlook, By Connected Pen Injectors (2020-2028) ($MN)
• Table 119 Middle East & Africa Smart Drug Delivery System Market Outlook, By Connected Inhalers (2020-2028) ($MN)
• Table 120 Middle East & Africa Smart Drug Delivery System Market Outlook, By Connected Autoinjectors (2020-2028) ($MN)
• Table 121 Middle East & Africa Smart Drug Delivery System Market Outlook, By Connected Wearable Injectors (2020-2028) ($MN)
• Table 122 Middle East & Africa Smart Drug Delivery System Market Outlook, By Add-on Sensors (2020-2028) ($MN)
• Table 123 Middle East & Africa Smart Drug Delivery System Market Outlook, By Other Products (2020-2028) ($MN)
• Table 124 Middle East & Africa Smart Drug Delivery System Market Outlook, By Therapeutic Area (2020-2028) ($MN)
• Table 125 Middle East & Africa Smart Drug Delivery System Market Outlook, By Respiratory Disorders (2020-2028) ($MN)
• Table 126 Middle East & Africa Smart Drug Delivery System Market Outlook, By Neurological Disorders (2020-2028) ($MN)
• Table 127 Middle East & Africa Smart Drug Delivery System Market Outlook, By Hormonal Disorders (2020-2028) ($MN)
• Table 128 Middle East & Africa Smart Drug Delivery System Market Outlook, By Metabolic Disorders (2020-2028) ($MN)
• Table 129 Middle East & Africa Smart Drug Delivery System Market Outlook, By Other Therapeutic Areas (2020-2028) ($MN)
• Table 130 Middle East & Africa Smart Drug Delivery System Market Outlook, By Drug Delivery Mode (2020-2028) ($MN)
• Table 131 Middle East & Africa Smart Drug Delivery System Market Outlook, By Injectable (2020-2028) ($MN)
• Table 132 Middle East & Africa Smart Drug Delivery System Market Outlook, By Oral (2020-2028) ($MN)
• Table 133 Middle East & Africa Smart Drug Delivery System Market Outlook, By Inhalation (2020-2028) ($MN)
• Table 134 Middle East & Africa Smart Drug Delivery System Market Outlook, By End User (2020-2028) ($MN)
• Table 135 Middle East & Africa Smart Drug Delivery System Market Outlook, By Hospitals (2020-2028) ($MN)
• Table 136 Middle East & Africa Smart Drug Delivery System Market Outlook, By Home Care (2020-2028) ($MN)
• Table 137 Middle East & Africa Smart Drug Delivery System Market Outlook, By Clinics (2020-2028) ($MN)
• Table 138 Middle East & Africa Smart Drug Delivery System Market Outlook, By Others End Users (2020-2028) ($MN)